Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling

Journal of Virology

Volumn 87, Issue 24, 2013, Pages 13853-13867

  Griffiths, David A ^a   Abdul Sada, Hussein ^a   Knight, Laura M ^a   Jackson, Brian R ^a   Richards, Kathryn ^a   Prescott, Emma L ^a   Howard S Peach, A ^b   Eric Blair, G ^a   Macdonald, Andrew ^a   Whitehouse, Adrian ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE 2A AALPHA; PHOSPHOPROTEIN PHOSPHATASE 2A ABETA; PHOSPHOPROTEIN PHOSPHATASE 4C; UNCLASSIFIED DRUG; VIRUS SMALL T ANTIGEN;

ANTIGEN FUNCTION; ARTICLE; CARCINOGENESIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HOST PATHOGEN INTERACTION; IMMUNE DYSREGULATION; INFLAMMATION; INNATE IMMUNITY; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; NONHUMAN; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TRANSCRIPTION REGULATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANTIGENS, VIRAL, TUMOR; CARCINOMA, MERKEL CELL; CELL LINE; HUMANS; I-KAPPA B KINASE; IMMUNITY, INNATE; MERKEL CELL POLYOMAVIRUS; NF-KAPPA B; PHOSPHORYLATION; POLYOMAVIRUS INFECTIONS; PROTEIN BINDING; TUMOR VIRUS INFECTIONS;

EID: 84888066126     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02159-13     Document Type: Article

References (66)

1. Becker JC, Schrama D, Houben R. 2009. Merkel cell carcinoma. Cell. Mol. Life Sci. 66:1-8.
2. Agelli M, Clegg LX. 2003. Epidemiology of primary Merkel cell carcinoma in the United States. J. Am. Acad. Dermatol. 49:832-841.
3. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. 2002. Merkel cell carcinoma and HIV infection. Lancet 359:497-498.
4. Penn I, First MR. 1999. Merkel's cell carcinoma in organ recipients:report of 41 cases. Transplantation 68:1717-1721.
5. Feng H, Shuda M, Chang Y, Moore PS. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-1100.
6. Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y. 2008. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc. Natl. Acad. Sci. U.S.A. 105:16272-16277.
7. zur Hausen H. 2008. Novel human polyomaviruses-Re-emergence of a well known virus family as possible human carcinogens. Int. J. Cancer 123:247-250.
8. Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, Moore PS, Becker JC. 2010. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J. Virol. 84:7064-7072.
9. Bikel I, Loeken MR. 1992. Involvement of simian virus-40 (Sv40) small T-antigen in transactivation of Sv40 early and late promoters. J. Virol. 66:1489-1494.
10. Cicala C, Avantaggiati ML, Graessmann A, Rundell K, Levine AS, Carbone M. 1994. Simian-virus-40 small-T antigen stimulates viral DNA replication in permissive monkey cells. J. Virol. 68:3138-3144.
11. Moens U, Van Ghelue M, Johannessen M. 2007. Oncogenic potentials of the human polyomavirus regulatory proteins. Cell. Mol. Life Sci. 64:1656-1678.
12. Sablina AA, Hahn WC. 2008. SV40 small T antigen and PP2A phosphatase in cell transformation. Cancer And Metastasis Rev. 27:137-146.
13. Arroyo JD, Hahn WC. 2005. Involvement of PP2A in viral and cellular transformation. Oncogene 24:7746-7755.
14. Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS. 2011. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J. Clin. Invest. 121:3623-3634.
15. Kwun HJ, Shuda M, Feng H, Camacho CJ, Moore PS, Chang Y. 2013. Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCF(Fbw7). Cell Host Microbe 14:125-135.
16. Richards KH, Macdonald A. 2011. Putting the brakes on the anti-viral response:negative regulators of type I interferon (IFN) production. Microbes Infect. 13:291-302.
17. Gilmore TD, Herscovitch M. 2006. Inhibitors of NF-kappa B signaling:785 and counting. Oncogene 25:6887-6899.
18. Karin M, Ben-Neriah Y. 2000. Phosphorylation meets ubiquitination:the control of NF-kappa B activity. Annu. Rev. Immunol. 18:621-663.
19. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD. 2006. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation. Nat. Cell Biol. 8:398-406.
20. Scheidereit C. 2006. IkappaB kinase complexes:gateways to NF-kappaB activation and transcription. Oncogene 25:6685-6705.
21. Hayden MS, Ghosh S. 2004. Signaling to NF-kappa B. Genes Dev. 18:2195-2224.
22. Le Negrate G. 2012. Viral interference with innate immunity by preventing NF-kappaB activity. Cell. Microbiol. 14:168-181.
23. Joo MS, Hahn YS, Kwon MJ, Sadikot RT, Blackwell TS, Christman JW. 2005. HepatitisCvirus core protein suppresses NF-kappa B activation and cyclooxygenase-2 expression by direct interaction with I kappa B kinase beta. J. Virol. 79:7648-7657.
24. Spitkovsky D, Hehner SP, Hofmann TG, Moller A, Schmitz ML. 2002. The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the I kappa B kinase complex. J. Biol. Chem. 277:25576-25582.
25. Randall CM, Jokela JA, Shisler JL. 2012. The MC159 protein from the molluscum contagiosum poxvirus inhibits NF-kappaB activation by interacting with the IkappaB kinase complex. J. Immunol. 188:2371-2379.
26. Fliss PM, Jowers TP, Brinkmann MM, Holstermann B, Mack C, Dickinson P, Hohenberg H, Ghazal P, Brune W. 2012. Viral mediated redirection of NEMO/IKKgamma to autophagosomes curtails the inflammatory cascade. PLoS Pathog. 8:e1002517.
27. Powell PP, Dixon LK, Parkhouse RME. 1996. An I kappa B homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J. Virol. 70:8527-8533.
28. Tait SWG, Reid EB, Greaves DR, Wileman TE, Powell PP. 2000. Mechanism of inactivation of NF-kappa B by a viral homologue of I kappa B alpha-signal-induced release of I kappa B alpha results in binding of the viral homologue to NF-kappa B. J. Biol. Chem. 275:34656-34664.
29. Camus-Bouclainville C, Fiette L, Bouchiha S, Pignolet A, Counor D, Filipe U, Gelfi J, Messud-Petit F. 2004. A virulence factor of myxoma virus colocalizes with NF-kappa B in the nucleus and interferes with inflammation. J. Virol. 78:2510-2516.
30. Moreno CS, Ramachandran S, Ashby DG, Laycock N, Plattner CA, Chen W, Hahn WC, Pallas DC. 2004. Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56 gamma knockdown. Cancer Res. 64:6978-6988.
31. Jackson BR, Boyne JR, Noerenberg M, Taylor A, Hautbergue GM, Walsh MJ, Wheat R, Blackbourn DJ, Wilson SA, Whitehouse A. 2011. An interaction between KSHV ORF57 and UIF provides mRNA-adaptor redundancy in herpesvirus intronless mRNA export. PLoS Pathog. 7:e1002138.
32. Mankouri J, Fragkoudis R, Richards KH, Wetherill LF, Harris M, Kohl A, Elliott RM, Macdonald A. 2010. Optineurin negatively regulates the induction of IFN beta in response to RNA virus infection. PLoS Pathog. 6:e1000778.
33. Macdonald A, Crowder K, Street A, McCormick C, Saksela K, Harris M. 2003. The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling. J. Biol. Chem. 278:17775-17784.
34. Gould F, Harrison SM, Hewitt EW, Whitehouse A. 2009. Kaposi's sarcomaassociated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway. J. Virol. 83:6727-6738.
35. Hall KT, Stevenson AJ, Goodwin DJ, Gibson PC, Markham AF, Whitehouse A. 1999. The activation domain of herpesvirus saimiri R protein interacts with the TATA-binding protein. J. Virol. 73:9756-7337.
36. Boyne JR, Jackson BR, Taylor A, Macnab SA, Whitehouse A. 2010. Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs.EMBOJ. 29:1851-1864.
37. Goodwin DJ, Whitehouse A. 2001. A gamma-2 herpesvirus nucleocytoplasmic shuttle protein interacts with importin alpha 1 and alpha 5. J. Biol. Chem. 276:19905-19912.
38. Griffiths R, Whitehouse A. 2007. Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2. J. Virol. 81:4021-4032.
39. Hall KT, Giles MS, Calderwood MA, Goodwin DJ, Matthews DA, Whitehouse A. 2002. The herpesvirus saimiri open reading frame 73 gene product interacts with the cellular protein p32. J. Virol. 76:11612-11622.
40. Emmott E, Rodgers MA, Macdonald A, McCrory S, Ajuh P, Hiscox JA. 2010. Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus. Mol. Cell. Proteomics 9:1920-1936.
41. Jourdan SS, Osorio F, Hiscox JA. 2012. An interactome map of the nucleocapsid protein from a highly pathogenic North American porcine reproductive and respiratory syndrome virus strain generated using SILAC-based quantitative proteomics. Proteomics 12:1015-1023.
42. Taylor A, Jackson BR, Noerenberg M, Hughes DJ, Boyne JR, Verow M, Harris M, Whitehouse A. 2011. Mutation of a C-terminal motif affects Kaposi's sarcoma-associated herpesvirus ORF57 RNA binding, nuclear trafficking, and multimerization. J. Virol. 85:7881-7891.
43. Huang TT, Wuerzberger-Davis SM, Wu Z-H, Miyamoto S. 2003. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115:565.
44. Jager S, Bucci C, Tanida I, Ueno T, Kominami E, Saftig P, Eskelinen EL. 2004. Role for Rab7 in maturation of late autophagic vacuoles. J. Cell Sci. 117:4837-4848.
45. Deretic V. 2008. Autophagosome and phagosome. Methods Mol. Biol. 445:1-10.
46. Cheng J, DeCaprio JA, Fluck MM, Schaffhausen BS. 2009. Cellular transformation by simian virus 40 and murine polyoma virus T Antigens. Semin. Cancer Biol. 19:218-228.
47. Trinkle-Mulcahy L, Boulon S, Lam YW, Urcia R, Boisvert FM, Vandermoere F, Morrice NA, Swift S, Rothbauer U, Leonhardt H, Lamond A. 2008. Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes. J. Cell Biol. 183:223-239.
48. Munday DC, Surtees R, Emmott E, Dove BK, Digard P, Barr JN, Whitehouse A, Matthews D, Hiscox JA. 2012. Using SILAC and quantitative proteomics to investigate the interactions between viral and host proteomes. Proteomics 12:666-672.
49. Arora R, Shuda M, Guastafierro A, Feng H, Toptan T, Tolstov Y, Normolle D, Vollmer LL, Vogt A, Domling A, Brodsky JL, Chang Y, Moore PS. 2012. Survivin is a therapeutic target in merkel cell carcinoma. Sci. Transl. Med. 4:133-156.
50. Hein J, Boichuk S, Wu J, Cheng Y, Freire R, Jat PS, Roberts TM, Gjoerup OV. 2009. Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding. J. Virol. 83:117-127.
51. Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C, Collins M. 2003. KSHV vFLIP binds to IKK-gamma to activate IKK. J. Cell Sci. 116:3721-3728.
52. Shembade N, Harhaj NS, Yamamoto M, Akira S, Harhaj EW. 2007. The human T-cell leukemia virus type 1 tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappa B activation. J. Virol. 81:13735-13742.
53. Li HY, Liu H, Wang CH, Zhang JY, Man JH, Gao YF, Zhang PJ, Li WH, Zhao J, Pan X, Zhou T, Gong WL, Li AL, Zhang XM. 2008. Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1. Nat. Immunol. 9:533-541.
54. Li S, Wang L, Berman MA, Zhang Y, Dorf ME. 2006. RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. Mol. Cell 24:497-509.
55. Brechmann M, Mock T, Nickles D, Kiessling M, Weit N, Breuer R, Muller W, Wabnitz G, Frey F, Nicolay JP, Booken N, Samstag Y, Klemke CD, Herling M, Boutros M, Krammer PH, Arnold R. 2012. A PP4 holoenzyme balances physiological and oncogenic nuclear factorkappa B signaling in T lymphocytes. Immunity 37:697-708.
56. Barisic S, Strozyk E, Peters N, Walczak H, Kulms D. 2008. Identification of PP2A as a crucial regulator of the NF-kappaB feedback loop:its inhibition by UVB turns NF-kappaB into a pro-apoptotic factor. Cell Death Differ. 15:1681-1690.
57. Clark K, Nanda S, Cohen P. 2013. Molecular control of the NEMO family of ubiquitin-binding proteins. Nat. Rev. Cancer 13:673-685.
58. Sontag E, Sontag JM, Garcia A. 1997. Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappa B activation. EMBO J. 16:5662-5671.
59. Nardi VSY, Santamaria-Barria JA, Cosper AK, Lam Q, Faber AC, Boland GM, Yeap BY, Bergethon K, Scialabba VL, Tsao H, Settleman J, Ryan DP, Borger DR, Bhan AK, Hoang MP, Iafrate AJ, Cusack JC, Engelman JA, Dias-Santagata D. 2012. Activation of PI3K signaling in Merkel cell carcinoma. Clin. Cancer Res. 18:1227-1236.
60. Andrabi S, Hwang JH, Choe JK, Roberts TM, Schaffhausen BS. 2011. Comparisons between murine polyomavirus and simian virus 40 show significant differences in small T antigen function. J. Virol. 85:10649-10658.
61. Janssens V, Goris J. 2001. Protein phosphatase 2A:a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353:417-439.
62. Wang SS, Esplin ED, Li JL, Huang LY, Gazdar A, Minna J, Evans GA. 1998. Alterations of the PPP2R1B gene in human lung and colon cancer. Science 282:284-287.
63. Yang SI, Lickteig RL, Estes R, Rundell K, Walter G, Mumby MC. 1991. Control of protein phosphatase-2a by simian virus-40 small-T antigen. Mol. Cell. Biol. 11:1988-1995.
64. Lubert EJ, Hong YL, Sarge KD. 2001. Interaction between protein phosphatase 5 and the A subunit of protein phosphatase 2A-evidence for a heterotrimeric form of protein phosphatase 5. J. Biol. Chem. 276:38582-38587.
65. Skinner J, Sinclair C, Romeo C, Armstrong D, Charbonneau H, Rossie S. 1997. Purification of a fatty acid-stimulated protein-serine/threonine phosphatase from bovine brain and its identification as a homolog of protein phosphatase 5. J. Biol. Chem. 272:22464-22471.
66. You DJ, Kim YL, Park CR, Kim DK, Yeom J, Lee C, Ahn C, Seong JY, Hwang JI. 2010. Regulation of IkappaB kinase by GbetaL through recruitment of the protein phosphatases. Mol. Cells 30:527-532.